TrialMuscle & nerve2022

Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses.

Robert G Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.